{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:53:21Z","timestamp":1788940401989,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005343","name":"Fundaci\u00f3n IMSS","doi-asserted-by":"publisher","award":["R-2021-1305-007"],"award-info":[{"award-number":["R-2021-1305-007"]}],"id":[{"id":"10.13039\/501100005343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Humanidades, Ciencias y Tecnolog\u00edas","doi-asserted-by":"publisher","award":["967146"],"award-info":[{"award-number":["967146"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35853-3","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:45:15Z","timestamp":1771425915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of ABCG2 gene variants with urate levels in Mexican patients with type 2 diabetes and chronic kidney disease"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0786-988X","authenticated-orcid":false,"given":"Francisco","family":"Mendoza-Carrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria Elizabeth","family":"V\u00e1zquez-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika Fabiola","family":"G\u00f3mez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Parra-Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Orozco-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Carolina","family":"Gonz\u00e1lez-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes del Carmen","family":"Rizo-de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Far\u00edas-Basulto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caridad \u00c1urea","family":"Leal-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"issue":"6","key":"35853_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.semnephrol.2020.12.006","volume":"40","author":"C Estiverne","year":"2020","unstructured":"Estiverne, C., Mandal, A. K. & Mount, D. B. Molecular pathophysiology of uric acid homeostasis. Semin Nephrol. 40 (6), 535\u2013549. https:\/\/doi.org\/10.1016\/j.semnephrol.2020.12.006 (2020).","journal-title":"Semin Nephrol."},{"key":"35853_CR2","doi-asserted-by":"publisher","unstructured":"Zhang, M. et al. Prevalence of hyperuricemia among Chinese adults: findings from two nationally representative cross-sectional surveys in 2015-16 and 2018-19. Front. Immunol. 12791983. https:\/\/doi.org\/10.3389\/fimmu.2021.791983 (2021).","DOI":"10.3389\/fimmu.2021.791983"},{"issue":"9","key":"35853_CR3","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s10067-018-4130-2","volume":"37","author":"Y Kim","year":"2018","unstructured":"Kim, Y., Kang, J. & Kim, G. T. Prevalence of hyperuricemia and its associated factors in the general Korean population: an analysis of a population-based nationally representative sample. Clin. Rheumatol. 37 (9), 2529\u20132538. https:\/\/doi.org\/10.1007\/s10067-018-4130-2 (2018).","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"35853_CR4","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/art.40807","volume":"71","author":"M Chen-Xu","year":"2019","unstructured":"Chen-Xu, M., Yokose, C., Rai, S. K., Pillinger, M. H. & Choi, H. K. Contemporary prevalence of gout and hyperuricemia in the united States and decadal trends: the National health and nutrition examination Survey, 2007\u20132016. Arthritis Rheumatol. 71 (6), 991\u2013999. https:\/\/doi.org\/10.1002\/art.40807 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"35853_CR5","unstructured":"Shamah-Levy, T. et al. Encuesta Nacional De Salud Y Nutrici\u00f3n Continua 2023. Resultados Nacionales (Instituto Nacional de Salud P\u00fablica, 2024)."},{"issue":"1","key":"35853_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12872-025-04529-7","volume":"25","author":"Z Zhang","year":"2025","unstructured":"Zhang, Z. et al. The new definition of metabolic syndrome including hyperuricemia improves its prognostic value: results from NHANES database. BMC Cardiovasc. Disord. 25 (1), 93. https:\/\/doi.org\/10.1186\/s12872-025-04529-7 (2025).","journal-title":"BMC Cardiovasc. Disord"},{"key":"35853_CR7","doi-asserted-by":"publisher","unstructured":"Nakayama, A. et al. Dysuricemia Biomedicines ;11(12). https:\/\/doi.org\/10.3390\/biomedicines11123169 (2023).","DOI":"10.3390\/biomedicines11123169"},{"issue":"2","key":"35853_CR8","doi-asserted-by":"publisher","first-page":"e56864","DOI":"10.1371\/journal.pone.0056864","volume":"8","author":"Q Lv","year":"2013","unstructured":"Lv, Q. et al. High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS One. 8 (2), e56864. https:\/\/doi.org\/10.1371\/journal.pone.0056864 (2013).","journal-title":"PLoS One"},{"issue":"9","key":"35853_CR9","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.2337\/dc09-0288","volume":"32","author":"S Kodama","year":"2009","unstructured":"Kodama, S. et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 32 (9), 1737\u20131742. https:\/\/doi.org\/10.2337\/dc09-0288 (2009).","journal-title":"Diabetes Care"},{"key":"35853_CR10","doi-asserted-by":"publisher","unstructured":"Liu, J. et al. Two-Year changes in hyperuricemia and risk of diabetes: A five-year prospective cohort study. J. Diabetes Res. 20186905720. https:\/\/doi.org\/10.1155\/2018\/6905720 (2018).","DOI":"10.1155\/2018\/6905720"},{"issue":"69","key":"35853_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11906-017-0770-x","volume":"9","author":"I Mortada","year":"2017","unstructured":"Mortada, I. & Hyperuricemia Type 2 diabetes mellitus, and hypertension: an emerging association. Curr. Hypertens. Rep. 9 (69), 5. https:\/\/doi.org\/10.1007\/s11906-017-0770-x (2017).","journal-title":"Curr. Hypertens. Rep."},{"issue":"5","key":"35853_CR12","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","volume":"67","author":"UM Khosla","year":"2005","unstructured":"Khosla, U. M. et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 67 (5), 1739\u20131742. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00273.x (2005).","journal-title":"Kidney Int."},{"issue":"1","key":"35853_CR13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s12891-024-07595-8","volume":"25","author":"J Tu","year":"2024","unstructured":"Tu, J. et al. BMI mediates the association of serum uric acid with bone health: a cross-sectional study of the National health and nutrition examination survey (NHANES). BMC Musculoskelet. Disord. 25 (1), 482. https:\/\/doi.org\/10.1186\/s12891-024-07595-8 (2024).","journal-title":"BMC Musculoskelet. Disord"},{"issue":"8","key":"35853_CR14","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.2337\/dc08-0349","volume":"31","author":"A Brandstatter","year":"2008","unstructured":"Brandstatter, A. et al. Sex-specific association of the putative Fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. Diabetes Care. 31 (8), 1662\u20131667. https:\/\/doi.org\/10.2337\/dc08-0349 (2008).","journal-title":"Diabetes Care"},{"key":"35853_CR15","doi-asserted-by":"publisher","unstructured":"Chen, Y. J. et al. Association of ABCG2 rs2231142 allele and Bmi with hyperuricemia in an East Asian population. Front. Genet. 12709887. https:\/\/doi.org\/10.3389\/fgene.2021.709887 (2021).","DOI":"10.3389\/fgene.2021.709887"},{"issue":"10","key":"35853_CR16","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1097\/HJH.0000000000001417","volume":"35","author":"L Scheepers","year":"2017","unstructured":"Scheepers, L. et al. Uric acid and blood pressure: exploring the role of uric acid production in the Maastricht study. J. Hypertens. 35 (10), 1968\u20131975. https:\/\/doi.org\/10.1097\/HJH.0000000000001417 (2017).","journal-title":"J. Hypertens."},{"issue":"10","key":"35853_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11906-016-0684-z","volume":"18","author":"SG Mallat","year":"2016","unstructured":"Mallat, S. G., Al Kattar, S., Tanios, B. Y. & Jurjus, A. Hyperuricemia, hypertension, and chronic kidney disease: an emerging association. Curr. Hypertens. Rep. 18 (10), 74. https:\/\/doi.org\/10.1007\/s11906-016-0684-z (2016).","journal-title":"Curr. Hypertens. Rep."},{"issue":"8","key":"35853_CR18","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jash.2015.05.010","volume":"9","author":"A Leiba","year":"2015","unstructured":"Leiba, A., Vinker, S., Dinour, D., Holtzman, E. J. & Shani, M. Uric acid levels within the normal range predict increased risk of hypertension: a cohort study. J. Am. Soc. Hypertens. 9 (8), 600\u2013609. https:\/\/doi.org\/10.1016\/j.jash.2015.05.010 (2015).","journal-title":"J. Am. Soc. Hypertens."},{"issue":"1","key":"35853_CR19","doi-asserted-by":"publisher","first-page":"19988","DOI":"10.1038\/s41598-022-23478-1","volume":"12","author":"Q Li","year":"2022","unstructured":"Li, Q. et al. Triglyceride-glucose index is significantly associated with the risk of hyperuricemia in patients with diabetic kidney disease. Sci. Rep. 12 (1), 19988. https:\/\/doi.org\/10.1038\/s41598-022-23478-1 (2022).","journal-title":"Sci. Rep."},{"key":"35853_CR20","doi-asserted-by":"publisher","unstructured":"Wang, L., Zhang, T., Liu, Y., Tang, F. & Xue, F. Association of serum uric acid with metabolic syndrome and its components: a Mendelian randomization analysis. Biomed. Res. Int. 20206238693. https:\/\/doi.org\/10.1155\/2020\/6238693 (2020).","DOI":"10.1155\/2020\/6238693"},{"issue":"1","key":"35853_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1053\/j.ajkd.2012.07.021","volume":"61","author":"DI Jalal","year":"2013","unstructured":"Jalal, D. I., Chonchol, M., Chen, W. & Targher, G. Uric acid as a target of therapy in CKD. Am. J. Kidney Dis. 61 (1), 134\u2013146. https:\/\/doi.org\/10.1053\/j.ajkd.2012.07.021 (2013).","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"35853_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12967-025-06145-7","volume":"23","author":"R Miyazaki","year":"2025","unstructured":"Miyazaki, R. et al. First verification of human small intestinal uric acid secretion and effect of ABCG2 polymorphisms. J. Transl Med. 23 (1), 257. https:\/\/doi.org\/10.1186\/s12967-025-06145-7 (2025).","journal-title":"J. Transl Med."},{"key":"35853_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.13947","author":"B Sarkadi","year":"2020","unstructured":"Sarkadi, B., Homolya, L. & Hegedus, T. The ABCG2\/BCRP transporter and its variants - from structure to pathology. FEBS Lett. https:\/\/doi.org\/10.1002\/1873-3468.13947 (2020).","journal-title":"FEBS Lett."},{"key":"35853_CR24","doi-asserted-by":"publisher","unstructured":"Rivera-Paredez, B. et al. Influence of genetic and non-genetic risk factors for serum uric acid levels and hyperuricemia in Mexicans. Nutrients 11 (6). https:\/\/doi.org\/10.3390\/nu11061336 (2019).","DOI":"10.3390\/nu11061336"},{"key":"35853_CR25","doi-asserted-by":"publisher","unstructured":"Macias-Kauffer, L. R. et al. Genetic contributors to serum uric acid levels in Mexicans and their effect on premature coronary artery disease. Int. J. Cardiol. 279168\u2013279173. https:\/\/doi.org\/10.1016\/j.ijcard.2018.09.107 (2019).","DOI":"10.1016\/j.ijcard.2018.09.107"},{"key":"35853_CR26","doi-asserted-by":"publisher","unstructured":"Yang, B. et al. A genome-wide association study identifies common variants influencing serum uric acid concentrations in a Chinese population. BMC Med. Genomics. 710. https:\/\/doi.org\/10.1186\/1755-8794-7-10 (2014).","DOI":"10.1186\/1755-8794-7-10"},{"issue":"1","key":"35853_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12881-020-0987-4","volume":"21","author":"J Liu","year":"2020","unstructured":"Liu, J., Yang, W., Li, Y., Wei, Z. & Dan, X. ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population. BMC Med. Genet. 21 (1), 54. https:\/\/doi.org\/10.1186\/s12881-020-0987-4 (2020).","journal-title":"BMC Med. Genet."},{"issue":"1","key":"35853_CR28","doi-asserted-by":"publisher","first-page":"9679","DOI":"10.1038\/s41598-025-93312-x","volume":"15","author":"M Liang","year":"2025","unstructured":"Liang, M. et al. Analysis of ABCG2 gene rs2231142 single nucleotide polymorphism and risk factors in hyperuricemia. Sci. Rep. 15 (1), 9679. https:\/\/doi.org\/10.1038\/s41598-025-93312-x (2025).","journal-title":"Sci. Rep."},{"issue":"1","key":"35853_CR29","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1038\/s41467-020-16525-w","volume":"11","author":"KM Hoque","year":"2020","unstructured":"Hoque, K. M. et al. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion. Nat. Commun. 11 (1), 2767. https:\/\/doi.org\/10.1038\/s41467-020-16525-w (2020).","journal-title":"Nat. Commun."},{"issue":"8","key":"35853_CR30","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1111\/cts.13318","volume":"15","author":"MO Pilon","year":"2022","unstructured":"Pilon, M. O. et al. An association study of ABCG2 rs2231142 on the concentrations of allopurinol and its metabolites. Clin. Transl Sci. 15 (8), 2024\u20132034. https:\/\/doi.org\/10.1111\/cts.13318 (2022).","journal-title":"Clin. Transl Sci."},{"issue":"1","key":"35853_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12881-020-01147-2","volume":"21","author":"T Lukkunaprasit","year":"2020","unstructured":"Lukkunaprasit, T. et al. The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis. BMC Med. Genet. 21 (1), 210. https:\/\/doi.org\/10.1186\/s12881-020-01147-2 (2020).","journal-title":"BMC Med. Genet."},{"issue":"9654","key":"35853_CR32","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","volume":"372","author":"A Dehghan","year":"2008","unstructured":"Dehghan, A. et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 372 (9654), 1953\u20131961. https:\/\/doi.org\/10.1016\/S0140-6736(08)61343-4 (2008).","journal-title":"Lancet"},{"key":"35853_CR33","doi-asserted-by":"publisher","unstructured":"Cleophas, M. C. et al. ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches. Pharmagenomics Pers. Med. 10129\u201310142. https:\/\/doi.org\/10.2147\/PGPM.S105854 (2017).","DOI":"10.2147\/PGPM.S105854"},{"issue":"9","key":"35853_CR34","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3346\/jkms.2017.32.9.1451","volume":"32","author":"CN Son","year":"2017","unstructured":"Son, C. N. et al. ABCG2 polymorphism is associated with hyperuricemia in a study of a community-based Korean cohort. J. Korean Med. Sci. 32 (9), 1451\u20131459. https:\/\/doi.org\/10.3346\/jkms.2017.32.9.1451 (2017).","journal-title":"J. Korean Med. Sci."},{"issue":"6","key":"35853_CR35","doi-asserted-by":"publisher","first-page":"103235","DOI":"10.1016\/j.arcmed.2025.103235","volume":"56","author":"GE Vazquez-Rivera","year":"2025","unstructured":"Vazquez-Rivera, G. E. et al. Single nucleotide variants of the SLC2A9 gene are associated with hyperuricemia in Mexican patients with type 2 diabetes. Arch. Med. Res. 56 (6), 103235. https:\/\/doi.org\/10.1016\/j.arcmed.2025.103235 (2025).","journal-title":"Arch. Med. Res."},{"key":"35853_CR36","doi-asserted-by":"publisher","unstructured":"Kim, G. H. & Jun, J. B. Altered serum uric acid levels in kidney disorders. Life (Basel). 12 (11). https:\/\/doi.org\/10.3390\/life12111891 (2022).","DOI":"10.3390\/life12111891"},{"issue":"11","key":"35853_CR37","doi-asserted-by":"publisher","first-page":"e21108","DOI":"10.1016\/j.heliyon.2023.e21108","volume":"9","author":"S Wu","year":"2023","unstructured":"Wu, S., Kong, M., Song, Y. & Peng, A. Ethnic disparities in bidirectional causal effects between serum uric acid concentrations and kidney function: Trans-ethnic Mendelian randomization study. Heliyon 9 (11), e21108. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21108 (2023).","journal-title":"Heliyon"},{"issue":"6","key":"35853_CR38","doi-asserted-by":"publisher","first-page":"e39321","DOI":"10.1371\/journal.pone.0039321","volume":"7","author":"T Lyngdoh","year":"2012","unstructured":"Lyngdoh, T. et al. Serum uric acid and adiposity: Deciphering causality using a bidirectional Mendelian randomization approach. PLoS One. 7 (6), e39321. https:\/\/doi.org\/10.1371\/journal.pone.0039321 (2012).","journal-title":"PLoS One"},{"issue":"11","key":"35853_CR39","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s11255-017-1686-8","volume":"49","author":"J Liu","year":"2017","unstructured":"Liu, J. et al. Mendelian randomization analysis indicates serum urate has a causal effect on renal function in Chinese women. Int. Urol. Nephrol. 49 (11), 2035\u20132042. https:\/\/doi.org\/10.1007\/s11255-017-1686-8 (2017).","journal-title":"Int. Urol. Nephrol."},{"issue":"6","key":"35853_CR40","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/nep.12679","volume":"22","author":"YP Hsieh","year":"2017","unstructured":"Hsieh, Y. P. et al. The role of uric acid in chronic kidney disease patients. Nephrol. (Carlton). 22 (6), 441\u2013448. https:\/\/doi.org\/10.1111\/nep.12679 (2017).","journal-title":"Nephrol. (Carlton)"},{"key":"35853_CR41","doi-asserted-by":"publisher","unstructured":"American Diabetes, A. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 43(Suppl 1), S14-S31. (2020). https:\/\/doi.org\/10.2337\/dc20-S002","DOI":"10.2337\/dc20-S002"},{"key":"35853_CR42","doi-asserted-by":"publisher","unstructured":"KDIGO. Chapter 1: Definition and classification of CKD. Kidney Int Suppl. 2013;3(1):19\u201362. (2011). https:\/\/doi.org\/10.1038\/kisup.2012.64","DOI":"10.1038\/kisup.2012.64"},{"issue":"4","key":"35853_CR43","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1053\/j.ajkd.2010.02.337","volume":"55","author":"AS Levey","year":"2010","unstructured":"Levey, A. S. & Stevens, L. A. Estimating GFR using the CKD epidemiology collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am. J. Kidney Dis. 55 (4), 622\u2013627. https:\/\/doi.org\/10.1053\/j.ajkd.2010.02.337 (2010).","journal-title":"Am. J. Kidney Dis."},{"key":"35853_CR44","unstructured":"Sambrook, J., Fritsch, E. F. & Maniatis, T. Molecular Cloning: a Laboratory Manual (Cold Spring Harbor Laboratory Press, 1989)."},{"issue":"1","key":"35853_CR45","doi-asserted-by":"publisher","first-page":"12255","DOI":"10.1038\/s41598-018-29665-3","volume":"8","author":"GC Mannino","year":"2018","unstructured":"Mannino, G. C. et al. The polymorphism rs35767 at IGF1 locus is associated with serum urate levels. Sci. Rep. 8 (1), 12255. https:\/\/doi.org\/10.1038\/s41598-018-29665-3 (2018).","journal-title":"Sci. Rep."},{"issue":"1","key":"35853_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12916-017-0890-9","volume":"15","author":"T Bardin","year":"2017","unstructured":"Bardin, T. & Richette, P. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 15 (1), 123. https:\/\/doi.org\/10.1186\/s12916-017-0890-9 (2017).","journal-title":"BMC Med."},{"issue":"11","key":"35853_CR47","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.2215\/CJN.03140315","volume":"10","author":"S De Cosmo","year":"2015","unstructured":"De Cosmo, S. et al. Serum uric acid and risk of CKD in type 2 diabetes. Clin. J. Am. Soc. Nephrol. 10 (11), 1921\u20131929. https:\/\/doi.org\/10.2215\/CJN.03140315 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"35853_CR48","doi-asserted-by":"publisher","unstructured":"Zhou, Y., Wang, H. & Gao, W. Elevated blood glucose can promote uric acid excretion: a cross-sectional study involving urinary glucose and urinary uric acid in China. Diabetes Metab. Syndr. Obes. 174553\u2013174563. https:\/\/doi.org\/10.2147\/DMSO.S472686 (2024).","DOI":"10.2147\/DMSO.S472686"},{"issue":"12","key":"35853_CR49","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.numecd.2014.06.012","volume":"24","author":"G Sesti","year":"2014","unstructured":"Sesti, G. et al. Low Circulating insulin-like growth factor-1 levels are associated with high serum uric acid in nondiabetic adult subjects. Nutr. Metab. Cardiovasc. Dis. 24 (12), 1365\u20131372. https:\/\/doi.org\/10.1016\/j.numecd.2014.06.012 (2014).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"1","key":"35853_CR50","doi-asserted-by":"publisher","first-page":"F173","DOI":"10.1152\/ajprenal.00462.2018","volume":"316","author":"A Novikov","year":"2019","unstructured":"Novikov, A. et al. SGLT2 Inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1. Am. J. Physiol. Ren. Physiol. 316 (1), F173\u2013F185. https:\/\/doi.org\/10.1152\/ajprenal.00462.2018 (2019).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"4","key":"35853_CR51","doi-asserted-by":"publisher","first-page":"842","DOI":"10.4314\/ahs.v18i4.2","volume":"18","author":"MJ Cheserek","year":"2018","unstructured":"Cheserek, M. J., Shi, Y. & Le, G. Association of hyperuricemia with metabolic syndrome among university workers: sex and occupational differences. Afr. Health Sci. 18 (4), 842\u2013851. https:\/\/doi.org\/10.4314\/ahs.v18i4.2 (2018).","journal-title":"Afr. Health Sci."},{"issue":"2","key":"35853_CR52","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s10157-016-1288-2","volume":"21","author":"T Kumagai","year":"2017","unstructured":"Kumagai, T. et al. Time to target uric acid to retard CKD progression. Clin. Exp. Nephrol. 21 (2), 182\u2013192. https:\/\/doi.org\/10.1007\/s10157-016-1288-2 (2017).","journal-title":"Clin. Exp. Nephrol."},{"issue":"2","key":"35853_CR53","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1253\/circj.CJ-20-0406","volume":"85","author":"I Hisatome","year":"2021","unstructured":"Hisatome, I. et al. Uric acid as a risk factor for chronic kidney disease and cardiovascular disease - Japanese guideline on the management of asymptomatic hyperuricemia. Circ. J. 85 (2), 130\u2013138. https:\/\/doi.org\/10.1253\/circj.CJ-20-0406 (2021).","journal-title":"Circ. J."},{"key":"35853_CR54","doi-asserted-by":"publisher","unstructured":"Nakayama, S. et al. Detailed association between serum uric acid levels and the incidence of chronic kidney disease stratified by sex in middle-aged adults. Atherosclerosis 330107\u2013330113. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.06.908 (2021).","DOI":"10.1016\/j.atherosclerosis.2021.06.908"},{"issue":"1","key":"35853_CR55","doi-asserted-by":"publisher","first-page":"e0244106","DOI":"10.1371\/journal.pone.0244106","volume":"16","author":"YB Son","year":"2021","unstructured":"Son, Y. B. et al. The effect of baseline serum uric acid on chronic kidney disease in normotensive, normoglycemic, and non-obese individuals: A health checkup cohort study. PLoS One. 16 (1), e0244106. https:\/\/doi.org\/10.1371\/journal.pone.0244106 (2021).","journal-title":"PLoS One"},{"issue":"6","key":"35853_CR56","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/dmrr.2768","volume":"32","author":"YH Chang","year":"2016","unstructured":"Chang, Y. H. et al. Serum uric acid level as an indicator for CKD regression and progression in patients with type 2 diabetes mellitus-a 4.6-year cohort study. Diabetes Metab. Res. Rev. 32 (6), 557\u2013564. https:\/\/doi.org\/10.1002\/dmrr.2768 (2016).","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"3","key":"35853_CR57","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/hr.2016.139","volume":"40","author":"Y Ohta","year":"2017","unstructured":"Ohta, Y. et al. Effective uric acid-lowering treatment for hypertensive patients with hyperuricemia. Hypertens. Res. 40 (3), 259\u2013263. https:\/\/doi.org\/10.1038\/hr.2016.139 (2017).","journal-title":"Hypertens. Res."},{"issue":"2","key":"35853_CR58","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.atherosclerosis.2009.12.013","volume":"210","author":"A Brandstatter","year":"2010","unstructured":"Brandstatter, A. et al. Sex and age interaction with genetic association of atherogenic uric acid concentrations. Atherosclerosis 210 (2), 474\u2013478. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.12.013 (2010).","journal-title":"Atherosclerosis"},{"issue":"1","key":"35853_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13073-024-01304-9","volume":"16","author":"R Xiang","year":"2024","unstructured":"Xiang, R. et al. Recent advances in polygenic scores: translation, equitability, methods and FAIR tools. Genome Med. 16 (1), 33. https:\/\/doi.org\/10.1186\/s13073-024-01304-9 (2024).","journal-title":"Genome Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35853-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35853-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35853-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:58:21Z","timestamp":1774346301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35853-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35853"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35853-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9753"}}